METTL3-mediated m6A methylation of lncRNA PVT1 promotes the progression of oral squamous cell carcinoma via the miR-185-5p/SERPINB4 axis
- 1 January 2025
- journal article
- Published by e-Century Publishing Corporation in American Journal of Cancer Research
- Vol. 15 (6) , 2872-2889
Abstract
Oral squamous cell carcinoma (OSCC) is one of the most common malignant tumors of the head and neck region. Plasmacytoma variant translocation 1 (PVT1), a long non-coding RNA (lncRNA), has been found to be overexpressed in multiple cancers, including OSCC. However, the upstream and downstream regulatory mechanisms through which PVT1 influences the malignant progression of OSCC remain to be further explored. In this study, PVT1 was confirmed to be overexpressed in OSCC tissues, and its roles in promoting OSCC cell proliferation, migration and invasion were identified. RNA-sequencing was used to screen the candidate target genes of PVT1, among which serpin family B member 4 (SERPINB4) was the most downregulated. SERPINB4 promoted OSCC cell proliferation, migration and invasion. In addition, mechanistic investigations demonstrated that PVT1 regulates SERPINB4 by sponging miR-185-5p in OSCC cells. Furthermore, SERPINB4 overexpression or miR-185-5p knockdown partly restores the decrease of OSCC cell proliferation and metastasis induced by PVT1 knockdown. Additional studies revealed that methyltransferase-like 3 (METTL3)-mediated N6-methyladenosine (m6A) modification induced the upregulation of PVT1 by stabilizing its RNA transcript. In conclusion, elevated expression of PVT1 in OSCC is associated with poor prognosis and promotes tumor development. METTL3 promotes PVT1 stability through m6A deposition and upregulates its expression in OSCC, which could upregulate SERPINB4 by sponging miR-185-5p, and ultimately promoting OSCC growth and metastasis. These findings suggest that PVT1 could serve as a potential biomarker and therapeutic target for OSCC.Keywords
This publication has 44 references indexed in Scilit:
- Diagnostic accuracy of serum biomarkers for head and neck cancer: A systematic review and meta-analysisCritical Reviews in Oncology/Hematology, 2016
- The multilayered complexity of ceRNA crosstalk and competitionNature, 2014
- Probing N6-methyladenosine RNA modification status at single nucleotide resolution in mRNA and long noncoding RNARNA, 2013
- The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISCNature Structural & Molecular Biology, 2012
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?Cell, 2011
- Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomasVirchows Archiv, 2011
- PTEN/AKT pathway involved in histone deacetylases inhibitor induced cell growth inhibition and apoptosis of oral squamous cell carcinoma cellsOral Oncology, 2009
- Relative levels of SCCA2 and SCCA1 mRNA in primary tumors predicts recurrent disease in squamous cell cancer of the head and neckInternational Journal of Cancer, 2001
- Circulating serpin tumor markers SCCA1 and SCCA2 are not actively secreted but reside in the cytosol of squamous carcinoma cellsInternational Journal of Cancer, 2000
- Metalloproteinase domain structure, cellular invasion and metastasisBiochemical Society Transactions, 1994